is a biotechnology company established in 2007 and is situated in West Vancouver, Canada. It specializes in developing and promoting S-Adenosyl Methionine, a prescription drug used as a dietary supplement. The company has been making strides in pioneering biotechnology advancements with innovative solutions and has garnered significant attention within the Biotechnology, Health Care, Health, and Wellness industries. Notably, MSI Methylation Sciences Inc. secured a substantial $30.00M Venture Round investment on 06 October 2016, with GHS Fund as the major investor.
No recent news or press coverage available for Msi Methylation Sciences INC.